암 생검 시장, 점유율, 규모, 동향, 산업 분석 보고서 : 제품 유형별, 용도별, 지역별, 부문별 예측(2024-2032년)

The global cancer biopsy market size is expected to reach USD 92.09 billion by 2032, according to a new study by Polaris Market Research. The report "Cancer Biopsy Market Share, Size, Trends, Industry Analysis Report, By Type (Liquid, Biopsy, Tissue Biopsy, and Others); By Product Type; By Application; By Region; Segment Forecast, 2024- 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

A biopsy is a medical procedure that involves extracting tissue from any part of the body to detect diseases. Different methods, including needle-based or surgical extraction, are used. Imaging tests such as MRIs and CT scans can identify abnormalities, but they cannot differentiate between cancerous and non-cancerous cells. Therefore, biopsies are essential to confirm malignancy diagnoses and involve detailed cellular analysis.

Advancements in liquid biopsies have significantly influenced the growth of the cancer biopsy market. This innovative technique analyzes genetic material in the bloodstream, making it possible to detect and monitor specific cancer types in a non-invasive approach.

Biopsies offer crucial insights into the biology of different cancer types. This information is instrumental in identifying potential drug targets and designing clinical trials to evaluate new therapies. Biopsies are also used to monitor treatment response and identify mechanisms of resistance, contributing to the development of more effective drugs and combination therapies.

The cancer biopsy market is facing numerous challenges. Advanced biopsy techniques and molecular profiling technologies are not readily available in areas with limited resources. Additionally, interpreting complex genomic data requires specialized expertise, which highlights the need for ongoing education and training in oncology. Invasive biopsy procedures can cause discomfort to patients, leading to reluctance to undergo the process. Moreover, the cost of biopsy procedures and related technologies can be too high for some individuals and healthcare systems. It is vital to overcome these challenges to ensure equal access to high-quality biopsy services and to maximize their impact on cancer diagnosis and treatment.

Cancer Biopsy Market Report Highlights

• The liquid biopsy segment is expected to grow at the highest CAGR during the projected period on account of wide usage

• The kits and consumables segment accounted for the largest market share in 2022, which is mainly driven by cost-effectiveness and higher performance.

• The breast cancer segment held a significant market revenue share in 2022, mainly due to its high prevalence rate

• North America region dominated the market with a majority share in 2022, owing to exponential growth in the technology and advanced healthcare system

• The global key market players include: Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., Danaher Corporation, F. Hoffmann-La Roche Ltd., Hologic, Inc

Polaris Market Research has segmented the cancer biopsy market report based on type, product type, application, and region:

Cancer Biopsy, Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Liquid, Biopsy
• Tissue Biopsy
• Others

Cancer Biopsy, Product Type Outlook (Revenue - USD Billion, 2019 - 2032)

• Kits and Consumables
• Instruments
• Services

Cancer Biopsy, Application Outlook (Revenue - USD Billion, 2019 - 2032)

• Breast Cancer
• Cervical Cancer
• Lung Cancer
• Colorectal Cancer
• Others

Cancer Biopsy, Regional Outlook (Revenue - USD Billion, 2019 - 2032)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• France
• Italy
• Spain
• Russia
• Netherlands
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Malaysia
• Latin America
• Argentina
• Brazil
• Mexico
• Middle East & Africa
• UAE
• Saudi Arabia
• Israel
• South Africa

Table of Contents

1. Introduction

• 1.1. Report Description
  • 1.1.1. Objectives of the Study
  • 1.1.2. Market Scope
  • 1.1.3. Assumptions
• 1.2. Stakeholders

2. Executive Summary

• 2.1. Market Highlights

3. Research Methodology

• 3.1. Overview
  • 3.1.1. Data Mining
• 3.2. Data Sources
  • 3.2.1. Primary Sources
  • 3.2.2. Secondary Sources

4. Global Cancer Biopsy Market Insights

• 4.1. Cancer Biopsy Market - Application Snapshot
• 4.2. Cancer Biopsy Market Dynamics
  • 4.2.1. Drivers and Opportunities
    • 4.2.1.1. Increase in cancer cases is projected to spur the product demand
    • 4.2.1.2. Advancements in molecular diagnostics
  • 4.2.2. Restraints and Challenges
    • 4.2.2.1. High costs associated with cancer biopsy tests
• 4.3. Porter's Five Forces Analysis
  • 4.3.1. Bargaining Power of Suppliers (Moderate)
  • 4.3.2. Threats of New Entrants: (Low)
  • 4.3.3. Bargaining Power of Buyers (Moderate)
  • 4.3.4. Threat of Substitute (Moderate)
  • 4.3.5. Rivalry among existing firms (High)
• 4.4. PESTEL Analysis
• 4.5. Cancer Biopsy Market Application Trends
• 4.6. Value Chain Analysis
• 4.7. COVID-19 Impact Analysis

5. Global Cancer Biopsy Market, by Type

• 5.1. Key Findings
• 5.2. Introduction
  • 5.2.1. Global Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
• 5.3. Liquid, Biopsy
  • 5.3.1. Global Cancer Biopsy Market, by Liquid, Biopsy, by Region, 2019-2032 (USD Billion)
• 5.4. Tissue Biopsy
  • 5.4.1. Global Cancer Biopsy Market, by Tissue Biopsy, by Region, 2019-2032 (USD Billion)
• 5.5. Others
  • 5.5.1. Global Cancer Biopsy Market, by Others, by Region, 2019-2032 (USD Billion)

6. Global Cancer Biopsy Market, by Product Type

• 6.1. Key Findings
• 6.2. Introduction
  • 6.2.1. Global Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
• 6.3. Kits and Consumables
  • 6.3.1. Global Cancer Biopsy Market, by Kits and Consumables, by Region, 2019-2032 (USD Billion)
• 6.4. Instruments
  • 6.4.1. Global Cancer Biopsy Market, by Instruments, by Region, 2019-2032 (USD Billion)
• 6.5. Services
  • 6.5.1. Global Cancer Biopsy Market, by Services, by Region, 2019-2032 (USD Billion)

7. Global Cancer Biopsy Market, by Application

• 7.1. Key Findings
• 7.2. Introduction
  • 7.2.1. Global Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
• 7.3. Breast Cancer
  • 7.3.1. Global Cancer Biopsy Market, by Breast Cancer, By Region, 2019-2032 (USD Billion)
• 7.4. Cervical Cancer
  • 7.4.1. Global Cancer Biopsy Market, by Cervical Cancer, By Region, 2019-2032 (USD Billion)
• 7.5. Lung Cancer
  • 7.5.1. Global Cancer Biopsy Market, by Lung Cancer, By Region, 2019-2032 (USD Billion)
• 7.6. Colorectal Cancer
  • 7.6.1. Global Cancer Biopsy Market, by Colorectal Cancer, By Region, 2019-2032 (USD Billion)
• 7.7. Others
  • 7.7.1. Global Cancer Biopsy Market, by Others, By Region, 2019-2032 (USD Billion)

8. Global Cancer Biopsy Market, by Geography

• 8.1. Key findings
• 8.2. Introduction
  • 8.2.1. Cancer Biopsy Market Assessment, By Geography, 2019-2032 (USD Billion)
• 8.3. Cancer Biopsy Market - North America
  • 8.3.1. North America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 8.3.2. North America: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 8.3.3. North America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.3.4. Cancer Biopsy Market - U.S.
    • 8.3.4.1. U.S.: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.4.2. U.S.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.4.3. U.S.: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.3.5. Cancer Biopsy Market - Canada
    • 8.3.5.1. Canada: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.3.5.2. Canada.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.3.5.3. Canada: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
• 8.4. Cancer Biopsy Market - Europe
  • 8.4.1. Europe: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 8.4.2. Europe.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 8.4.3. Europe: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.4. Cancer Biopsy Market - UK
    • 8.4.4.1. UK: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.4.2. UK.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.4.3. UK: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.5. Cancer Biopsy Market - France
    • 8.4.5.1. France: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.5.2. France.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.5.3. France: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.6. Cancer Biopsy Market - Germany
    • 8.4.6.1. Germany: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.6.2. Germany.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.6.3. Germany: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.7. Cancer Biopsy Market - Italy
    • 8.4.7.1. Italy: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.7.2. Italy.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.7.3. Italy: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.8. Cancer Biopsy Market - Spain
    • 8.4.8.1. Spain: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.8.2. Spain.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.8.3. Spain: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.9. Cancer Biopsy Market - Netherlands
    • 8.4.9.1. Netherlands: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.9.2. Netherlands.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.9.3. Netherlands: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.4.10. Cancer Biopsy Market - Russia
    • 8.4.10.1. Russia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.4.10.2. Russia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.4.10.3. Russia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
• 8.5. Cancer Biopsy Market - Asia Pacific
  • 8.5.1. Asia Pacific: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 8.5.2. Asia Pacific.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 8.5.3. Asia Pacific: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.4. Cancer Biopsy Market - China
    • 8.5.4.1. China: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.4.2. China.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.4.3. China: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.5. Cancer Biopsy Market - India
    • 8.5.5.1. India: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.5.2. India.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.5.3. India: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.6. Cancer Biopsy Market - Malaysia
    • 8.5.6.1. Malaysia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.6.2. Malaysia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.6.3. Malaysia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.7. Cancer Biopsy Market - Japan
    • 8.5.7.1. Japan: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.7.2. Japan.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.7.3. Japan: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.8. Cancer Biopsy Market - Indonesia
    • 8.5.8.1. Indonesia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.8.2. Indonesia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.8.3. Indonesia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.5.9. Cancer Biopsy Market - South Korea
    • 8.5.9.1. South Korea: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.5.9.2. South Korea.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.5.9.3. South Korea: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
• 8.6. Cancer Biopsy Market - Middle East & Africa
  • 8.6.1. Middle East & Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 8.6.2. Middle East & Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 8.6.3. Middle East & Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6.4. Cancer Biopsy Market - Saudi Arabia
    • 8.6.4.1. Saudi Arabia: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.4.2. Saudi Arabia.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.4.3. Saudi Arabia: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6.5. Cancer Biopsy Market - UAE
    • 8.6.5.1. UAE: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.5.2. UAE.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.5.3. UAE: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6.6. Cancer Biopsy Market - Israel
    • 8.6.6.1. Israel: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.6.2. Israel.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.6.3. Israel: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.6.7. Cancer Biopsy Market - South Africa
    • 8.6.7.1. South Africa: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.6.7.2. South Africa.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.6.7.3. South Africa: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
• 8.7. Cancer Biopsy Market - Latin America
  • 8.7.1. Latin America: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
  • 8.7.2. Latin America.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
  • 8.7.3. Latin America: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7.4. Cancer Biopsy Market - Mexico
    • 8.7.4.1. Mexico: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.4.2. Mexico.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.4.3. Mexico: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7.5. Cancer Biopsy Market - Brazil
    • 8.7.5.1. Brazil: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.5.2. Brazil.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.5.3. Brazil: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)
  • 8.7.6. Cancer Biopsy Market - Argentina
    • 8.7.6.1. Argentina: Cancer Biopsy Market, by Type, 2019-2032 (USD Billion)
    • 8.7.6.2. Argentina.: Cancer Biopsy Market, by Application, 2019-2032 (USD Billion)
    • 8.7.6.3. Argentina: Cancer Biopsy Market, by Product Type, 2019-2032 (USD Billion)

9. Competitive Landscape

• 9.1. Expansion and Acquisition Analysis
  • 9.1.1. Expansion
  • 9.1.2. Acquisitions
• 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

• 10.1. Abbott Laboratories
  • 10.1.1. Company Overview
  • 10.1.2. Financial Performance
  • 10.1.3. Product Benchmarking
  • 10.1.4. Recent Development
• 10.2. Becton, Dickinson and Company
  • 10.2.1. Company Overview
  • 10.2.2. Financial Performance
  • 10.2.3. Product Benchmarking
  • 10.2.4. Recent Development
• 10.3. Bio-Rad Laboratories, Inc.
  • 10.3.1. Company Overview
  • 10.3.2. Financial Performance
  • 10.3.3. Product Benchmarking
  • 10.3.4. Recent Development
• 10.4. Danaher Corporation
  • 10.4.1. Company Overview
  • 10.4.2. Financial Performance
  • 10.4.3. Product Benchmarking
  • 10.4.4. Recent Development
• 10.5. F. Hoffmann-La Roche Ltd.
  • 10.5.1. Company Overview
  • 10.5.2. Financial Performance
  • 10.5.3. Product Benchmarking
  • 10.5.4. Recent Development
• 10.6. Hologic, Inc.
  • 10.6.1. Company Overview
  • 10.6.2. Financial Performance
  • 10.6.3. Product Benchmarking
  • 10.6.4. Recent Development
• 10.7. Illumina, Inc.
  • 10.7.1. Company Overview
  • 10.7.2. Financial Performance
  • 10.7.3. Product Benchmarking
  • 10.7.4. Recent Development
• 10.8. Koninklijke Philips N.V.
  • 10.8.1. Company Overview
  • 10.8.2. Financial Performance
  • 10.8.3. Product Benchmarking
  • 10.8.4. Recent Development
• 10.9. Myriad Genetics, Inc.
  • 10.9.1. Company Overview
  • 10.9.2. Financial Performance
  • 10.9.3. Product Benchmarking
  • 10.9.4. Recent Development
• 10.10. NeoGenomics, Inc.
  • 10.10.1. Company Overview
  • 10.10.2. Financial Performance
  • 10.10.3. Product Benchmarking
  • 10.10.4. Recent Development
• 10.11. QIAGEN N.V.
  • 10.11.1. Company Overview
  • 10.11.2. Financial Performance
  • 10.11.3. Product Benchmarking
  • 10.11.4. Recent Development
• 10.12. Siemens Healthineers AG
  • 10.12.1. Company Overview
  • 10.12.2. Financial Performance
  • 10.12.3. Product Benchmarking
  • 10.12.4. Recent Development
• 10.13. Sysmex Corporation
  • 10.13.1. Company Overview
  • 10.13.2. Financial Performance
  • 10.13.3. Product Benchmarking
  • 10.13.4. Recent Development
• 10.14. Thermo Fisher Scientific Inc.
  • 10.14.1. Company Overview
  • 10.14.2. Financial Performance
  • 10.14.3. Product Benchmarking
  • 10.14.4. Recent Development
• 10.15. Veracyte, Inc.
  • 10.15.1. Company Overview
  • 10.15.2. Financial Performance
  • 10.15.3. Product Benchmarking
  • 10.15.4. Recent Development